{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:45:13Z","timestamp":1791402313350,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jinf.2016.06.011","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T08:09:42Z","timestamp":1467965382000},"page":"496-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients"],"prefix":"10.1016","volume":"73","author":[{"given":"Silvia","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ho","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.06.011_bib1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1704662","article-title":"Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis","volume":"34","author":"Jantunen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib2","first-page":"175","article-title":"Epidemiology and treatment approaches in management of invasive fungal infections","volume":"3","author":"Kriengkauykiat","year":"2011","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jinf.2016.06.011_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","article-title":"Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients","volume":"116","author":"Martino","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jinf.2016.06.011_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/344906","article-title":"High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation","volume":"36","author":"Hagen","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11046-009-9196-6","article-title":"Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint","volume":"168","author":"Bow","year":"2009","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jinf.2016.06.011_bib6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2013.05.018","article-title":"Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience","volume":"19","author":"Omer","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib7","first-page":"200","article-title":"Profiles of infectious complications on the outcomes for the recipients of allogeneic hematopoietic stem cell transplantation","volume":"72","author":"Rhee","year":"2007","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jinf.2016.06.011_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12879-015-1329-6","article-title":"Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study","volume":"15","author":"Harrison","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1631\/jzus.B1500005","article-title":"Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years","volume":"16","author":"Shi","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.jinf.2016.06.011_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.06.011_bib13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2013a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib14","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/605665","article-title":"Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)","volume":"49","author":"Girmenia","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective","volume":"44","author":"Tomblyn","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/13693780701885552","article-title":"Fungal infections in hematopoietic stem cell transplant recipients","volume":"46","author":"Marr","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.jinf.2016.06.011_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/13543784.10.2.269","article-title":"Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors","volume":"10","author":"Georgopapadakou","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jinf.2016.06.011_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jac\/46.3.485","article-title":"In\u00a0vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide","volume":"46","author":"Mikamo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.06.011_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00001432-200112000-00004","article-title":"Clinical efficacy of echinocandin antifungals","volume":"14","author":"Arathoon","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7164\/antibiotics.55.219","article-title":"Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus","volume":"55","author":"Hatano","year":"2002","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jinf.2016.06.011_bib22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2016.06.011_bib23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib24","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","article-title":"Laboratory diagnosis of invasive aspergillosis","volume":"5","author":"Hope","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2004.05031.x","article-title":"Advances in the molecular and serological diagnosis of invasive fungal infection in haemato-oncology patients","volume":"126","author":"McLintock","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jinf.2016.06.011_bib28","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1200\/JCO.2008.20.1178","article-title":"Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation","volume":"27","author":"Michallet","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jinf.2016.06.011_bib29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1994.12.4.827","article-title":"Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients","volume":"12","author":"O'Donnell","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jinf.2016.06.011_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","article-title":"Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group","volume":"25","author":"Wolff","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation","volume":"71","author":"Koh","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jinf.2016.06.011_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2016.06.011_bib33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2016.06.011_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1703332","article-title":"Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital","volume":"29","author":"Grow","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2015.181","article-title":"Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis","volume":"50","author":"Montesinos","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib36","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.jinf.2016.06.011_bib37","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/421952","article-title":"Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib38","first-page":"34","article-title":"Candidiasis in the transplant patient","volume":"77","author":"Clift","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2016.06.011_bib39","first-page":"635","article-title":"Variables predicting deep fungal infections in bone marrow transplant recipients","volume":"4","author":"Tollemar","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib40","first-page":"177","article-title":"Candida infections in bone marrow transplant recipients","volume":"8","author":"Verfaillie","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2016.06.011_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.06.011_bib42","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/JCM.40.4.1496-1499.2002","article-title":"Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis","volume":"40","author":"Viscoli","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2016.06.011_bib43","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316301566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316301566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:30Z","timestamp":1759008210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316301566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0163445316301566"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.06.011","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}